During its annual IDWeek, held Oct. 3-7 in San Francisco, the Infectious Diseases Society of America put the spotlight on the antibiotic pipeline, highlighting the following drugs making their way through the development and registration processes:
TetraPhase Pharmaceuticals Inc
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?